IceCure Medical Ltd (ICCM)
NASDAQ: ICCM · Real-Time Price · USD
1.205
+0.029 (2.49%)
Apr 1, 2025, 10:40 AM EDT - Market open
IceCure Medical Employees
As of December 31, 2023, IceCure Medical had 77 total employees, including 71 full-time and 6 part-time employees. The number of employees increased by 5 or 6.94% compared to the previous year.
Employees
77
Change (1Y)
5
Growth (1Y)
6.94%
Revenue / Employee
$42,740
Profits / Employee
-$198,935
Market Cap
68.17M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 77 | 5 | 6.94% |
Dec 31, 2022 | 72 | 8 | 12.50% |
Dec 31, 2021 | 64 | 17 | 36.17% |
Dec 31, 2020 | 47 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ICCM News
- 4 days ago - IceCure Medical Ltd (ICCM) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 5 days ago - IceCure Medical Reports 2024 Financial Results: 42% Growth in ProSense® Cryoablation Sales in North America - PRNewsWire
- 8 days ago - IceCure's ICESECRET Kidney Cancer Cryoablation Study Interim Results Presented at European Association of Urology Conference in Spain: 88.7% Recurrence-Free Rate - PRNewsWire
- 11 days ago - IceCure Medical to Report 2024 Full Year Financial & Operational Results on March 27, 2025 - PRNewsWire
- 12 days ago - IceCure Reports Updated Timeline and Progress with FDA Regarding Marketing Authorization for ProSense® Cryoablation in Early-Stage Breast Cancer - PRNewsWire
- 14 days ago - IceCure's ProSense® Cryoablation Featured in Six Studies Presented at St. Gallen International Breast Cancer Conference - PRNewsWire
- 15 days ago - IceCure Receives Notice of Allowance in China for Novel Cryogenic Pump for Next-Generation Cryoablation Technology - PRNewsWire
- 22 days ago - Breast Cancer Patients who Underwent IceCure's ProSense® Cryoablation in Japan Reported Significantly Higher Satisfaction than Patients who Underwent Standard of Care Surgery - PRNewsWire